# Brodalumab

## Lumicef 210mg/1.5mL inj

##### 臨採

| TAH Drug Code      | [ILUMI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ILUMI)                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Moderate to severe plaque psoriasis, pustular psoriasis.                                                                                                                                                                                                |
| Dosing             | SC, 210 mg at weeks 0, 1, and 2, followed by 210 mg once every 2 weeks.                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                           |
| Contraindications  | Crohn disease, Clinically significant hypersensitivity to brodalumab or any component of the formulation.                                                                                                                                               |
| Adverse Effects    | Common: Diarrhea (2.2%), Infectious disease (25.4%), Mycosis (1.8-2.4%), Arthralgia (4.7%), Headache (4.3%), Pain in throat (2.1%), Fatigue (2.6%) Serious: Neutropenia, Grade 3 or greater (0.5%), Cryptococcal meningitis, Suicidal thoughts, Suicide |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                           |

